f8b8fbff6d521b3b2d0a68c24ed0f8e3
APOAT
ROCHE DIAGNOSTICS GMBH·II·Ecuador ARCSA·Registered October 31, 2023
Device classification
- Risk class
- II
- Product type
- In Vitro Diagnostic
- Brand name
- ROCHE
- Commercial name
- 18-900 Reagents/Kits for IVD, Clinical Chemistry, Protein Assays
Registration information
- Analysis ID
- f8b8fbff6d521b3b2d0a68c24ed0f8e3
- Registration date
- October 31, 2023
- Expiration date
- October 31, 2028
Manufacturer
- City
- MANNHEIM
- Country
- GERMANY
- Address
- SANDHOFER STR. 116 68305 MANNHEIM
Product owner
- Name
- ROCHE DIAGNOSTICS GMBH
- Country
- GERMANY
Authorized representative
- Address
- AV SIMON BOLIVAR N/A Y VIA A NAYON
- Phone
- 3997100
Product use
QUANTITATIVE DETERMINATION OF APOLIPOPROTEIN A-1 IN HUMAN SERUM AND PLASMA.
About this record
Access comprehensive regulatory information for APOAT in the Ecuador medical device market through Pure Global AI's free database. This II medical device is registered under ARCSA ID f8b8fbff6d521b3b2d0a68c24ed0f8e3 and manufactured by ROCHE DIAGNOSTICS GMBH. The device was registered on October 31, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.